nipper Posted October 30, 2018 Share Posted October 30, 2018 You're not really getting anywhere if a second opinion from another machine delivers a different diagnosis. Link to comment Share on other sites More sharing options...
blacksheep Posted October 30, 2018 Share Posted October 30, 2018 Wonder if the RAP app tells you to get a second opinion - from another app Probably (for legal reasons) there's a message on their app to consult a human in case of uncertainty. May as well take the human option in the first place Link to comment Share on other sites More sharing options...
mme Posted October 5, 2019 Share Posted October 5, 2019 A lot of guts and glory if they've held but looks like RAP is now on a winner. If FDA is approved year end early 2020 this IMO is going places big time! Link to comment Share on other sites More sharing options...
nipper Posted October 6, 2019 Share Posted October 6, 2019 The company has received Therapeutic Goods Administration approval for its paediatric cough diagnostic. This follows CE Mark approval for both children and adults which allows the company to market the device across Europe. The bigger prize, achieving US FDA approval, is expected late in 2019 or early 2020. Morgans continues to fully risk commercial outcomes until there is insight into initial reception across Europe and Australia. There have also been positive results in the companyâââہ¡Ãƒâ€šÃ‚¬ÃƒÆ’¢Ã¢Ã¢â€š¬Ã…¾Ãƒâ€šÃ‚¢s sleep apnoea study, showing high rates of accuracy when compared with at-home comprehensive sleep studies. Speculative Buy (Add) maintained. Target is raised to $0.32 from $0.28. Link to comment Share on other sites More sharing options...
nipper Posted March 6, 2021 Share Posted March 6, 2021 ha, ha, got to laugh RAP finished down 1.8 per cent to 5.4c despite announcing a three-month pilot trial of its cough diagnostic smartphone app across the telemedicine services of a large European Union telehealth provider called Medgate. It's just an unpaid trial at this stage, but Medgate provides 6,000 telehealth consults a day, and well over 25 per cent of GP appointments are for chest infection or cost-related. At $5 a test, that could result in $1.65 million a year in revenue for ResApp, Morgans estimates. "While these numbers assume full take-up across the MG network, we know from the Aus telehealth customers that reality takes a bit more time," Morgans wrote in a research note. "What it does do is raise a flag across MG's EU competitors firstly that the technology exists, and importantly providing the external validation from one of the industry's biggest players that they see it as a value-add to their consults." The announcement "isn't a home run at this stage, but adds confidence in the technology and marketability within the telehealth space," Morgans says. The brokerage rates ResApp a speculative buy with a 13c price target. ....or, others that held RAP took advantage of this 'news' to find some buyers. Note the previous Morgans position, from 18 months ago : Speculative Buy (Add) maintained. Target is raised to $0.32 from $0.28. Link to comment Share on other sites More sharing options...
ShareCafe Admin Posted August 16, 2021 Share Posted August 16, 2021 ED of Corporate Affairs Brian Leedman presenting at this Friday's (20/08/21) Hidden Gems Webinar. Click HERE to register. Thanks Admin Link to comment Share on other sites More sharing options...
ShareCafe Admin Posted August 24, 2021 Share Posted August 24, 2021 Presentation from last week's HGW up. Digital health solutions for respiratory disease Thanks Admin Link to comment Share on other sites More sharing options...
nipper Posted September 10, 2021 Share Posted September 10, 2021 up 20% to 7c....... was 4 to 4.5c about two weeks ago. No announcements of note Link to comment Share on other sites More sharing options...
Share Cafe Admin Posted April 5 Share Posted April 5 Dr Tony Keating - CEO & MD presenting at this Friday's (8/4/22) Hidden Gems Webinar Register HERE Link to comment Share on other sites More sharing options...
Share Cafe Admin Posted June 14 Share Posted June 14 Tony Keating - CEO & Managing Director - presenting at this Friday's (17/6/22) Hidden Gems Webinar. Register HERE. Thanks Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now